NCT04282135View on ClinicalTrials.gov

Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling

CompletedOBSERVATIONAL
Enrollment

76

Participants

Timeline

Start Date

February 15, 2020

Primary Completion Date

May 8, 2020

Study Completion Date

June 30, 2020

Conditions
Influenza
Interventions
DIAGNOSTIC_TEST

MCC IMS

Diagnosis by MCC IMS

Trial Locations (1)

95445

Klinikum Bayreuth, Bayreuth

All Listed Sponsors
lead

Klinikum Bayreuth GmbH

INDUSTRY

NCT04282135 - Detection of Influenza or SARS-CoV-2 Infection by IMS of Nasal Air Sampling | Biotech Hunter | Biotech Hunter